Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
2019 · The Lancet · 526 citations
https://doi.org/10.1016/s0140-6736(18)32213-x
N
Neil Nathwani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
2.1K
Citations
14
h-index
16
i10-index
Neil Nathwani is an academic researcher from Moorfields Eye Hospital NHS Foundation Trust. The author has contributed to research in topics: Glaucoma and retinal disorders & Corneal surgery and disorders & Retinal Diseases and Treatments. The author has an h-index of 14, co-authored 28 publications.
ORCID: 0000-0003-4944-8183Papers by this author
worksSelective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
2019 · The Lancet · 526 citations
https://doi.org/10.1016/s0140-6736(18)32213-x
Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)
2020 · Ophthalmology · 64 citations
https://doi.org/10.1016/j.ophtha.2020.03.029
Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)
2020 · Ophthalmology · 64 citations
https://doi.org/10.1016/j.ophtha.2020.03.029
Selective laser trabeculoplasty (SLT) performed by optometrists—enablers and barriers to a shift in service delivery
2021 · Eye · 9 citations
https://doi.org/10.1038/s41433-021-01746-0
Optometrist-delivered selective laser trabeculoplasty in the HES – a training protocol and early service evaluation
2024 · Eye · 3 citations
https://doi.org/10.1038/s41433-024-03086-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat